TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ESLA

Estrella Immunopharma Inc.

Healthcare · Biotechnology

0.529$ +0.6% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Estrella Immunopharma Inc. (ESLA): report dates, earnings surprises, earnings call transcripts and the latest headlines.

Next report
Last report 08/13/2026
Earnings surprise by quarter (%)
Q3 24 · 25.0 % 24 Q4 24 · 75.0 % 24 Q1 25 · 45.5 % 25 Q2 25 · -25.0 % 25 Q3 25 · -85.7 % 25 Q4 25 · 85.7 % 25 Q1 26 · 73.7 % 26 Q2 26 · 44.4 % 26

EPS estimate beaten

Full history 6 of 9 quarters (67%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/08/2026 Estrella Immunopharma, Inc. (ESLA): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗
  • 08/21/2026 Estrella Immunopharma, Inc. (ESLA): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?